Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound

Henry H.Y. Tong, Zhen Du, Geng Nan Wang, H. M. Chan, Qi Chang, Leon C.M. Lai, Albert H.L. Chow, Y. Zheng

Research output: Contribution to journalArticlepeer-review

71 Citations (Scopus)

Abstract

Spray-freeze-drying (SFD) of oleanolic acid (OA), a BCS Class IV compound, with polyvinylpyrrolidone-40 (PVP-40) as stabilizer and sodium caprate (SC) as wetting agent and penetration enhancer produced kinetically stable, amorphous solid dispersion systems with superior in vitro dissolution performance, and better and more uniform absorption in comparison with commercial OA tablet. Relative to the SC-free formulation, the presence of SC in the formulation resulted in a significant increase in the in vivo absorption rate of OA while exerting no apparent impact on the extent of OA absorption. The SFD-processed OA formulations and commercial OA tablet generally exhibited large inter-animal variability in oral bioavailability, consistent with the absorption characteristics of BCS Class IV compounds. Inclusion of SC coupled with the replacement of OA with its sodium salt (OA-Na) in the formulation was shown to substantially decrease the observed absorption variability. Above results suggested that increases in both dissolution rate and intestinal permeability of BCS Class IV compounds, as exemplified by the SFD-processed dispersion system containing both OA-Na and SC, are critical to reducing the large inter-individual absorption variability commonly observed with this class of drugs.

Original languageEnglish
Pages (from-to)148-158
Number of pages11
JournalInternational Journal of Pharmaceutics
Volume404
Issue number1-2
DOIs
Publication statusPublished - 14 Feb 2011

Keywords

  • Dissolution
  • Oleanolic acid
  • Oral bioavailability
  • Sodium caprate
  • Sodium oleanolate
  • Spray freeze drying

Fingerprint

Dive into the research topics of 'Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound'. Together they form a unique fingerprint.

Cite this